{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T14:02:49Z","timestamp":1776780169710,"version":"3.51.2"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T00:00:00Z","timestamp":1597449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T00:00:00Z","timestamp":1597449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s00520-020-05681-w","type":"journal-article","created":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T12:02:21Z","timestamp":1597492941000},"page":"79-84","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Oral verruciform xanthoma in chronic graft-versus-host disease patients"],"prefix":"10.1007","volume":"29","author":[{"given":"Ori","family":"Bar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Elad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Batia","family":"Avni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jawad","family":"Abu-Tair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bianca","family":"Zaharia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiham","family":"Hanut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6062-6529","authenticated-orcid":false,"given":"Yehuda","family":"Zadik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,15]]},"reference":[{"key":"5681_CR1","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/0030-4220(71)90134-4","volume":"31","author":"WG Shafer","year":"1971","unstructured":"Shafer WG (1971) Verruciform xanthoma. Oral Surg Oral Med Oral Pathol 31:784\u2013789","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"5681_CR2","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1001\/archderm.1981.01650090045024","volume":"117","author":"A Buchner","year":"1981","unstructured":"Buchner A, Hansen LS, Merrell PW (1981) Verruciform xanthoma of the oral mucosa. Report of five cases and review of the literature. Arch Dermatol 117:563\u2013565","journal-title":"Arch Dermatol"},{"key":"5681_CR3","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s12105-011-0246-2","volume":"5","author":"S Shahrabi Farahani","year":"2011","unstructured":"Shahrabi Farahani S, Treister NS, Khan Z, Woo SB (2011) Oral verruciform xanthoma associated with chronic graft-versus-host disease: a report of five cases and a review of the literature. Head Neck Pathol 5:193\u2013198","journal-title":"Head Neck Pathol"},{"key":"5681_CR4","first-page":"331","volume-title":"Oral and maxillofacial pathology. 4th ed.","author":"BW Neville","year":"2016","unstructured":"Neville BW, Damm DD, Allen CM, Chi AC (2016) Epithelial pathology. In: Oral and maxillofacial pathology. 4th ed. Elsevier, St. Louis, pp 331\u2013421"},{"key":"5681_CR5","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0964-1955(96)00080-2","volume":"33","author":"HI Shin","year":"1997","unstructured":"Shin HI, Choi KS, Nagatsuka H, Murata M, Nagai N (1997) Verruciform xanthoma of the oral mucosa: an immunohistochemical and ultrastructural study of two cases. Oral Oncol 33:279\u2013283","journal-title":"Oral Oncol"},{"key":"5681_CR6","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/S1368-8375(00)00068-3","volume":"37","author":"PT Oliveira","year":"2001","unstructured":"Oliveira PT, Jaeger RG, Cabral LA, Carvalho YR, Costa AL, Jaeger MM (2001) Verruciform xanthoma of the oral mucosa. Report of four cases and a review of the literature. Oral Oncol 37:326\u2013331","journal-title":"Oral Oncol"},{"key":"5681_CR7","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1007\/s12105-019-01123-0","volume":"14","author":"AN Belknap","year":"2020","unstructured":"Belknap AN, Islam MN, Bhattacharyya I, Cohen DM, Fitzpatrick SG (2020) Oral verruciform xanthoma: a series of 212 cases and review of the literature. Head Neck Pathol 14:742\u2013748. https:\/\/doi.org\/10.1007\/s12105-019-01123-0","journal-title":"Head Neck Pathol"},{"key":"5681_CR8","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1097\/DAD.0b013e318225d33b","volume":"34","author":"JF Val-Bernal","year":"2012","unstructured":"Val-Bernal JF, Argueta L, Val D, Gonz\u00e1lez-Vela MC, Garijo MF (2012) Verruciform xanthoma is another condition associated with pseudoepitheliomatous hyperplasia. Am J Dermatopathol 34:341\u2013342","journal-title":"Am J Dermatopathol"},{"key":"5681_CR9","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.joms.2017.08.030","volume":"76","author":"S Whitefield","year":"2018","unstructured":"Whitefield S, Raiser V, Shuster A, Kleinman S, Shlomi B, Kaplan I (2018) The spectrum of oral lesions presenting clinically with papillary-verrucous features. J Oral Maxillofac Surg 76:545\u2013552","journal-title":"J Oral Maxillofac Surg"},{"key":"5681_CR10","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S1368-8375(02)00088-X","volume":"39","author":"HP Philipsen","year":"2003","unstructured":"Philipsen HP, Reichart PA, Takata T, Ogawa I (2003) Verruciform xanthoma: biological profile of 282 oral lesions based on a literature survey with nine new cases from Japan. Oral Oncol 39:325\u2013336","journal-title":"Oral Oncol"},{"key":"5681_CR11","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/j.1600-0560.1993.tb01256.x","volume":"20","author":"KF Helm","year":"1993","unstructured":"Helm KF, H\u00f6pfl RM, Kreider JW, Lookingbill DP (1993) Verruciform xanthoma in an immunocompromised patient: a case report and immunohistochemical study. J Cutan Pathol 20:84\u201386","journal-title":"J Cutan Pathol"},{"key":"5681_CR12","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1097\/00000372-199902000-00015","volume":"21","author":"KD Mannes","year":"1999","unstructured":"Mannes KD, Dekle CL, Requena L, Sangueza OP (1999) Verruciform xanthoma associated with squamous cell carcinoma. Am J Dermatopathol 21:66\u201369","journal-title":"Am J Dermatopathol"},{"key":"5681_CR13","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/0030-4220(93)90231-R","volume":"75","author":"CM Allen","year":"1993","unstructured":"Allen CM, Kapoor N (1993) Verruciform xanthoma in a bone marrow transplant recipient. Oral Surg Oral Med Oral Pathol 75:591\u2013594","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"5681_CR14","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/S0151-9638(06)71086-9","volume":"133","author":"V Sibaud","year":"2006","unstructured":"Sibaud V, Marit G, Demini\u00e8re C, Campana F, Taieb A, Fricain JC (2006) Multiple verruciform xanthomas of the oral mucosa associated with graft versus host disease. Ann Dermatol Venereol 133:995\u2013999","journal-title":"Ann Dermatol Venereol"},{"key":"5681_CR15","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1186\/s13104-017-2952-7","volume":"10","author":"G Capocasale","year":"2017","unstructured":"Capocasale G, Panzarella V, Tozzo P, Mauceri R, Rodolico V, Lauritano D, Campisi G (2017) Oral verruciform xanthoma and erythroplakia associated with chronic graft-versus-host disease: a rare case report and review of the literature. BMC Res Notes 10:631","journal-title":"BMC Res Notes"},{"key":"5681_CR16","doi-asserted-by":"publisher","unstructured":"Jenkyn I, Woodward G, Kelly A, Fowell C (2019) Oral verruciform xanthoma associated with stem cell transplantation and graft versus host disease in a paediatric patient. Bone Marrow Transplant. https:\/\/doi.org\/10.1038\/s41409-019-0772-1","DOI":"10.1038\/s41409-019-0772-1"},{"key":"5681_CR17","unstructured":"Elad S, Aljitawi O, Zadik Y. Oral graft versus host disease: a pictorial review and a guide for dental practitioners. Int Dent J, in press"},{"key":"5681_CR18","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.cxom.2017.04.006","volume":"25","author":"S Elad","year":"2017","unstructured":"Elad S, Zadik Y, Yarom N (2017) Oral complications of nonsurgical cancer therapies. Atlas Oral Maxillofac Surg Clin North Am 25:133\u2013147","journal-title":"Atlas Oral Maxillofac Surg Clin North Am"},{"key":"5681_CR19","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/0030-4220(80)90287-X","volume":"49","author":"BW Neville","year":"1980","unstructured":"Neville BW, Weathers DR (1980) Verruciform xanthoma. Oral Surg Oral Med Oral Pathol 49:429\u2013434","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"5681_CR20","first-page":"c60","volume":"78","author":"ET Stoopler","year":"2012","unstructured":"Stoopler ET, Desai B (2012) A tongue mass in a patient with oral lichen planus. J Can Dent Assoc 78:c60","journal-title":"J Can Dent Assoc"},{"key":"5681_CR21","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s12105-019-01001-9","volume":"13","author":"GN Mainville","year":"2019","unstructured":"Mainville GN (2019) Non-HPV papillary lesions of the oral mucosa: clinical and histopathologic features of reactive and neoplastic conditions. Head Neck Pathol 13:71\u201379","journal-title":"Head Neck Pathol"},{"key":"5681_CR22","first-page":"1615086","volume":"2018","author":"VI Theofilou","year":"2018","unstructured":"Theofilou VI, Sklavounou A, Argyris PP, Chrysomali E (2018) Oral verruciform xanthoma within lichen planus: a case report and literature review. Case Rep Dent 2018:1615086","journal-title":"Case Rep Dent"},{"key":"5681_CR23","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/ajh.24933","volume":"93","author":"Y Arai","year":"2018","unstructured":"Arai Y, Kondo T, Shigematsu A, Tanaka J, Ohashi K, Fukuda T, Hidaka M, Kobayashi N, Iwato K, Sakura T, Onizuka M, Ozawa Y, Eto T, Kurokawa M, Kahata K, Uchida N, Atsuta Y, Mizuta S, Kako S (2018) Improved prognosis with additional medium-dose VP16 to CY\/TBI in allogeneic transplantation for high risk ALL in adults. Am J Hematol 93:47\u201357","journal-title":"Am J Hematol"},{"key":"5681_CR24","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s12105-019-01003-7","volume":"13","author":"SJ Betz","year":"2019","unstructured":"Betz SJ (2019) HPV-related papillary lesions of the oral mucosa: a review. Head Neck Pathol 13:80\u201390","journal-title":"Head Neck Pathol"},{"key":"5681_CR25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.tripleo.2007.06.020","volume":"105","author":"S Elad","year":"2008","unstructured":"Elad S, Meyerowitz C, Shapira MY, Glick M, Bitan M, Amir G (2008) Oral posttransplantation lymphoproliferative disorder: an uncommon site for an uncommon disorder. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 105:59\u201364","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"5681_CR26","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.oraloncology.2005.02.001","volume":"41","author":"F Demarosi","year":"2005","unstructured":"Demarosi F, Lodi G, Carrassi A, Soligo D, Sardella A (2005) Oral malignancies following HSCT: graft versus host disease and other risk factors. Oral Oncol 41:865\u2013877","journal-title":"Oral Oncol"},{"key":"5681_CR27","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1097\/TP.0b013e3181f9caaa","volume":"90","author":"S Elad","year":"2010","unstructured":"Elad S, Zadik Y, Zeevi I, Miyazaki A, de Figueiredo MA, Or R (2010) Oral cancer in patients after hematopoietic stem-cell transplantation: long-term follow-up suggests an increased risk for recurrence. Transplantation 90:1243\u20131244","journal-title":"Transplantation"},{"key":"5681_CR28","doi-asserted-by":"publisher","first-page":"104550","DOI":"10.1016\/j.oraloncology.2019.104550","volume":"102","author":"S Warnakulasuriya","year":"2020","unstructured":"Warnakulasuriya S (2020) Oral potentially malignant disorders: a comprehensive review on clinical aspects and management. Oral Oncol, in press 102:104550","journal-title":"Oral Oncol"},{"key":"5681_CR29","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.bbmt.2015.03.024","volume":"21","author":"PA Carpenter","year":"2015","unstructured":"Carpenter PA, Kitko CL, Elad S, Flowers MED, Gea-Banacloche JC, Halter JP, Hoodin F, Johnston L, Lawitschka A, McDonald GB, Opipari AW, Savani BN, Schultz KR, Smith SR, Syrjala KL, Treister N, Vogelsang GB, Williams KM, Pavletic SZ, Martin PJ, Lee SJ, Couriel DR (2015) National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report. Biol Blood Marrow Transplant 21:1167\u20131187","journal-title":"Biol Blood Marrow Transplant"},{"key":"5681_CR30","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1080\/14656566.2017.1282464","volume":"18","author":"Y Zadik","year":"2017","unstructured":"Zadik Y, Elad S, Shapira A, Shapira MY (2017) Treatment of oral mucosal manifestations of chronic graft-versus-host disease: dexamethasone vs. budesonide. Expert Opin Pharmacother 18:235\u2013242","journal-title":"Expert Opin Pharmacother"},{"key":"5681_CR31","doi-asserted-by":"crossref","unstructured":"Zadik Y (2020) Pharmacotherapy of oral mucosal manifestations of chronic graft-versus-host disease: when? What? and How? Expert Opin Pharmacother, In press","DOI":"10.1080\/14656566.2020.1763307"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-020-05681-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-020-05681-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-020-05681-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T06:10:11Z","timestamp":1667801411000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-020-05681-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,15]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["5681"],"URL":"https:\/\/doi.org\/10.1007\/s00520-020-05681-w","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,15]]},"assertion":[{"value":"2 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Elad is a consultant to Falk Pharma GmbH; Dr. Zadik was a co-investigator in the BUM5 study, sponsored by Falk Pharma, GmbH","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}